Security Name | Asset Type |
Shares or Principal Amount |
Market Value |
Percent of Net Assets |
---|---|---|---|---|
Capital Group Central Cash Fund | Short Term | 5,590,337 | $559,145,485.00 | 4.87% |
U.S. Treasury 3.50% 9/30/2029 | Fixed Income | 185,987,000 | $185,442,151.00 | 1.62% |
U.S. Treasury 4.125% 8/15/2044 | Fixed Income | 116,438,000 | $115,546,597.00 | 1.01% |
AbbVie, Inc. 5.05% 3/15/2034 | Fixed Income | 94,978,000 | $99,242,797.00 | 0.87% |
JPMorgan Chase & Co. 5.294% 7/22/2035 (USD-SOFR + 1.46% on 7/22/2034) | Fixed Income | 95,271,000 | $99,399,378.00 | 0.87% |
Pacific Gas and Electric Co. 2.50% 2/1/2031 | Fixed Income | 103,300,000 | $90,541,727.00 | 0.79% |
U.S. Treasury 4.625% 5/15/2054 | Fixed Income | 79,964,000 | $86,748,434.00 | 0.76% |
Bristol-Myers Squibb Co. 5.20% 2/22/2034 | Fixed Income | 77,545,000 | $81,806,408.00 | 0.71% |
Chubb INA Holdings, LLC 5.00% 3/15/2034 | Fixed Income | 77,669,000 | $80,686,052.00 | 0.7% |
Cisco Systems, Inc. 5.05% 2/26/2034 | Fixed Income | 75,498,000 | $79,317,142.00 | 0.69% |
New Economy Assets Phase 1 Issuer, LLC, Series 2021-1, Class A1, 1.91% 10/20/2061 | Fixed Income | 85,198,000 | $78,619,096.00 | 0.69% |
Boeing Co. 2.75% 2/1/2026 | Fixed Income | 78,514,000 | $76,232,697.00 | 0.66% |
Pfizer Investment Enterprises Pte., Ltd. 5.30% 5/19/2053 | Fixed Income | 71,818,000 | $74,364,738.00 | 0.65% |
Pfizer Investment Enterprises Pte., Ltd. 4.75% 5/19/2033 | Fixed Income | 71,606,000 | $73,012,915.00 | 0.64% |
Morgan Stanley 5.32% 7/19/2035 (USD-SOFR + 1.555% on 7/19/2034) | Fixed Income | 67,459,000 | $70,077,691.00 | 0.61% |